Some patients reach this milestone faster, some slower, and the variation is normal
We will monitor your progress and well-being with regular follow-up appointments
Anyone with copper-metabolism disorders, active malignancy, or during pregnancy/breastfeeding should avoid it, and everyone should consult a licensed clinician first
The Therapeutic Goods Administration has issued a fresh warning to clinicians and consumers after laboratory testing confirmed that some imported weight-loss products marketed as GLP-1 therapies are counterfeit and contain no glucagon-like peptide-1 receptor agonists
However, as explained above, GLP-1Rs are not only localized to organs involved in the glycemic response, such as the pancreas and the liver, but are also expressed in various regions of the brain through neurons and glial cells [108]